TPST•Tempest Therapeutics appointed John W. Frederick to its board. Frederick most recently served as Skillsoft's chief financial officer and has more than three decades of executive leadership experience.
Tempest Therapeutics appointed John W. Frederick to its board of directors. He most recently served as Skillsoft's chief financial officer, overseeing financial reporting, investor relations and capital markets strategy, and brings more than three decades of executive leadership experience in corporate finance, operations and strategic transformation.
